Ipsilateral Femoral Autograft Reconstruction After Resection of a Pelvic Tumor

Biau, David J.; Thévenin, Fabrice; Dumaine, Valérie; Babinet, Antoine; Tomeno, Bernard; Anract, Philippe
January 2009
Journal of Bone & Joint Surgery, American Volume;Jan2009, Vol. 91-A Issue 1, p142
Academic Journal
Background: Reconstruction of bone after the resection of a pelvic tumor is challenging. The purpose of the present study was to evaluate the use of the ipsilateral femur as the graft material for reconstruction. Methods: We performed a retrospective review of thirteen patients with a malignant pelvic lesion who underwent resection followed by reconstruction with an ipsilateral femoral autograft and insertion of a total hip replacement. The study group included nine men and four women with a median age of fifty-one years at the time of the reconstruction. The diagnosis was chondrosarcoma in eight patients, metastasis in three, and myeloma and radiation-induced malignant disease in one each. The surviving patients were assessed functionally and radiographically; the cumulative probability of revision was estimated while taking into account competing risks. Results: The median duration of follow-up was forty-nine months. At the time of the latest follow-up, seven patients were alive and disease-free and six had died from metastatic disease. Four patients had had revision of the reconstruction, two for the treatment of mechanical complications and two for the treatment of infection. Three other patients had mechanical complications but had not had a revision. The cumulative probability of revision of the reconstruction for mechanical failure was 8% (95% confidence interval, 0% to 23%), 8% (95% confidence interval, 0% to 23%), and 16% (95% confidence interval, 0% to 39%) at one, two, and four years, respectively. Conclusions: Although it has attendant complications consistent with pelvic tumor surgery, an ipsilateral femoral autograft reconstruction may be an option for reconstruction of pelvic discontinuity in a subgroup of patients following tumor resection. This innovative procedure requires longer-term follow-up studies. Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.


Related Articles

  • Erythropoietin for autologous blood donation in total hip arthroplasty patients. Aksoy, M. Cemalettin; Tokgozoglu, A. Mazhar // Archives of Orthopaedic & Trauma Surgery;Mar2001, Vol. 121 Issue 3, p162 

    Forty patients who were scheduled for a total hip arthroplasty were enrolled in a prospective study and were randomly divided into two groups. Group 1 received recombinant human erythropoietin (300 U/kg twice a week), and group 2 received placebo. The medication was started 2 weeks before the...

  • Total knee arthroplasty in a patient with chronic occlusion of the superficial femoral artery. von Knoch, Marius; Funke, Edgar; Drobny, Tomas; Munzinger, Urs // Archives of Orthopaedic & Trauma Surgery;Mar2001, Vol. 121 Issue 3, p177 

    In a 67-year-old patient with severe valgus gonarthrosis and chronic occlusion of the superficial femoral artery on the same side, total knee replacement was performed without preceding angioplasty because the collateral circulation was intact. No tourniquet was used. To leave the peripatellar...

  • ÃŽmbunătăţirea calităţii vieÅ£ii pacienÅ£ilor cu artroplastie de ÅŸold. Ciortea, Viorela; Pop, Liviu; Irsay, Laszlo; Neacsu, Anda; Bondor, Cosmina // Palestrica of the Third Millennium Civilization & Sport;Mar2010, Vol. 11, p10 

    Background. Total hip arthroplasty has revolutionized the care of patients with severe hip disorders, relieving pain, recovering function and improving the quality of life. The aim of the rehabilitation treatment of total hip arthroplasty is to recover the patient's independence in daily...

  • Relationship between self-reported and performance-based tests in a hip and knee joint replacement population. Gandhi, Rajiv; Tsvetkov, Dmitry; Davey, J. Roderick; Syed, Khalid A.; Mahomed, Nizar N. // Clinical Rheumatology;Mar2009, Vol. 28 Issue 3, p253 

    Our objectives were: (1) to assess the relationship between self-reported measures (Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and Medical Outcomes Study Short Form-36 (SF-36)) and a performance-based timed-up-and-go (TUG) test in a hip and knee joint replacement...

  • Rivaroxaban the dominant thromboprophylactic.  // PharmacoEconomics & Outcomes News;11/28/2009, Issue 592, p9 

    The article discusses research on the cost effectiveness of rivaroxaban as thromboprophylactic in patients undergoing either total knee replacement (TKR) or total hip replacement (THR) surgery. It references a study by L. McCullagh et al, published in a 2009 issue of the journal...

  • Can cobalt levels estimate in-vivo wear of metal-on-metal bearings used in hip arthroplasty? Khan, M.; Kuiper, J. H.; Richardson, J. B. // Proceedings of the Institution of Mechanical Engineers -- Part H;Jan2007 Supplement 1, Vol. 221, p929 

    High levels of cobalt and chromium ions are detected in the blood and urine of patients with metal-on-metal (MoM) hip replacement. These elements are released as a result of wear at the bearing surfaces. Wear rates depend on a multitude of factors, which include the bearing geometry, carbon...

  • Intraoperative dislocation of a trial femoral head into the pelvis during total hip arthroplasty. Ziv, Yaron Bar; Backstein, David; Safir, Oleg; Kosashvili, Yona // Canadian Journal of Surgery;Jun2008 Supplement, Vol. 51, pE73 

    The article presents a case study of a 76-year-old woman with osteoarthritis who underwent a total hip arthroplasty. The patient was positioned in a lateral decubitus position under general anesthesia. No complications were found after the surgery. The mini-incision and femoral head trials are...

  • Duromâ„¢-Hüftoberflächenersatz. Goronzy, J.; Stiehler, M.; Kirschner, S.; Günther, K.-P. // Der Orthopäde;Sep2010, Vol. 39 Issue 9, p842 

    Background: Modern hip resurfacing as an alternative for stemmed total hip replacement therapy is associated with a specific risk profile. The aim of this study was therefore to assess the short- to midterm clinical and radiological outcome after introduction of the Duromâ„¢ Hip Resurfacing...

  • Risk Stratification Algorithm for Management of Patients with Metal-on-Metal Hip Arthroplasty: Consensus Statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, and The Hip Society. Young-Min Kwon; Lombardi, Adolph V.; Jacobs, Joshua J.; Fehring, Thomas K.; Lewis, Courtland G.; Cabanela, Miguel E. // Journal of Bone & Joint Surgery, American Volume;1/1/2014, Vol. 96 Issue 1, pe4(1) 

    The article examines on the advantages and disadvantages in management of risk stratification algorithm of patients having metal-on-metal (MoM) hip arthroplasty. It states that MOM has the possibility to reduce wear-induced osteolysis but has a greater implant stability due to use of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics